MOTO Medial® UKA for Knee Arthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a prospective, multi-center study, designed to assess mid-term performance of the MOTO Medial® Unicompartmental Knee Arthroplasty (UKA), with patient report outcomes, clinical findings and radiographic analysis.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on chemotherapy, radiation therapy, or immunosuppressive medications like steroids, you cannot participate in the trial.
Is MOTO Medial® UKA safe for humans?
How is the MOTO Medial® Unicompartmental Knee Arthroplasty treatment different from other treatments for knee arthritis?
The MOTO Medial® Unicompartmental Knee Arthroplasty (UKA) is unique because it focuses on replacing only the damaged part of the knee, which allows for a minimally invasive surgery and often results in quicker recovery and better knee function compared to total knee replacement. This approach is particularly beneficial for younger patients with isolated medial knee arthritis, offering high patient satisfaction and long-term success.678910
What data supports the effectiveness of the treatment MOTO Medial® Unicompartmental Knee Arthroplasty for knee arthritis?
Research shows that unicompartmental knee arthroplasty (UKA) is effective for treating medial knee osteoarthritis, with high patient satisfaction and good knee function, especially in younger patients. Long-term studies report high success rates, with 94% to 97% of UKA procedures still functioning well after 10 years.6791112
Who Is on the Research Team?
Mukesh Ahuja, MBBS, MS, CPI
Principal Investigator
Medacta USA
Are You a Good Fit for This Trial?
This trial is for adults over 18 with medial knee disease suitable for MOTO Medial® UKA, who can consent and comply with the study. Excluded are those with psychiatric illness, inflammatory arthritis, pregnancy, prior knee arthroplasty or infections, on immunosuppressants or narcotics, undergoing cancer treatments, or have metabolic disorders affecting bones.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative Evaluation
Collection of baseline data including medical and surgical history, demographics, and osteoarthritis severity
Surgery
Participants undergo the MOTO Medial® Unicompartmental Knee Arthroplasty
Post-operative Monitoring
Participants are monitored for safety, effectiveness, and complications with follow-up assessments at various intervals
Follow-up
Participants are monitored for long-term outcomes and implant survivorship
What Are the Treatments Tested in This Trial?
Interventions
- MOTO Medial® Unicompartmental Knee Arthroplasty
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medacta USA
Lead Sponsor